How do institutions report the findings of antibody identification panels for patients who have received Rh Immune Globulin?
A colleague reports that they would like updated information regarding how other institutions report the findings of antibody identification panels for patients who have received Rh Immune Globulin and how have a positive antibody screen, and only anti-D appears to be present by an antibody identification workup. The inquiring colleague wants to know if it would be acceptable to sign out the work up as "all clinically significant antibodies ruled out", or should they report that they have detected only "Rhig D"?
Editors' Note: The following previous discussions are germane to the above question:
The following comments have been received in response.
ADDENDA Sept. 1, 2010
- A colleague comments that she does not believe that the presence of passively acquired anti-D (following RhIg administration) should be reported as "no clinically signifigant antibodies are present". Anti-D from administered RhIg could definitely react with Rh Positive red cells. Commenting that anti-D, probably due to RhIg is present with no OTHER clinically significant antibodies would be more indicative of the true picture. Some institutions might want to manage such a patient with an immediate spin crossmatch with D-Negative blood. However, such an approach may not be compliant with current regulatory and accreditation requirements, and there may be a problem with handling those patients differently from all the others. Rather, a crossmatch through AHG would keep all patients with detectable anti-D handled alike.
Submit comments to the e-Network Forum at enetworkforum@cbbsweb.org
Ira A. Shulman, MD
CBBS e-Network Forum Senior Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Editor & Moderator
Elizabeth M. St. Lezin, MD
CBBS e-Network Forum Associate Editor & Moderator
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.